Cefazolin and Telmisartan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Telmisartan (telmisartan). Common drug interactions include cardio-respiratory arrest among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Telmisartan. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.
What is Cefazolin?
Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.
What is Telmisartan?
Telmisartan has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 9,163 Telmisartan users. Check the latest studies of Telmisartan.
24 people who take Cefazolin and Telmisartan together, and have interactions are studied.

What are the common drug interactions of Cefazolin and Telmisartan, by gender? *:
female:
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Post procedural complication
- Blood pressure decreased
- Bradycardia (abnormally slow heart action)
- Cardiac arrest
- Cardiovascular disorder (heart diseases)
- Chronic kidney disease
- Hypotension (abnormally low blood pressure)
- Interstitial lung disease
- Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
male:
- Chronic kidney disease
- Cardiac failure congestive
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Cardiac failure
- Hepatic failure (liver failure)
- Respiratory distress (difficulty in breathing)
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Drug ineffective
- Pneumococcal bacteraemia (infection confirmed by the isolation of streptococcus pneumoniae)
- Purulent pericarditis (localized infection of the pericardial space characterized by gross pus in the pericardium)
What are the common drug interactions of Cefazolin and Telmisartan, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Chronic kidney disease
40-49:
n/a
50-59:
- Cardiac failure
- Hepatic failure (liver failure)
- Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
- Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
60+:
- Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
- Chronic kidney disease
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Renal impairment (severely reduced kidney function)
- Respiratory distress (difficulty in breathing)
- Anaphylactic shock (severe and rapid and sometimes fatal hypersensitivity reaction to a substance)
- Hypotension (abnormally low blood pressure)
- Interstitial lung disease
- Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
- Drug ineffective
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 25.00%
- Pain: 5 people, 20.83%
- Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 16.67%
- Hyperlipidaemia (presence of excess lipids in the blood): 4 people, 16.67%
- High Blood Cholesterol: 4 people, 16.67%
- Psoriasis (immune-mediated disease that affects the skin): 3 people, 12.50%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 12.50%
- Blood Pressure Abnormal: 3 people, 12.50%
- Erysipelas (bacterial skin infection): 3 people, 12.50%
- Cardiac Disorder: 3 people, 12.50%
* Approximation only. Some reports may have incomplete information.
Do you take Cefazolin and Telmisartan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Cefazolin (15,157 reports)
- Telmisartan (9,163 reports)
Browse all drug interactions of Cefazolin and Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cefazolin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Telmisartan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cefazolin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Telmisartan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
- Kato Y, Mukai Y, Rane A, Inotsume N, Toda T, "The inhibitory effect of telmisartan on the metabolism of arachidonic acid by CYP2C9 and CYP2C8: an in vitro study", Biological and Pharmaceutical Bulletin, 2017 Sep .
- Kim HK, Youm JB, Lee SR, Lim SE, Lee SY, Ko TH, Nilius B, Noh JH, Ko KS, Rhee BD, Kim N, "The angiotensin receptor blocker and PPAR-γ agonist, telmisartan, delays inactivation of voltage-gated sodium channel in rat heart: novel mechanism of drug action", Pflügers Archiv-European Journal of Physiology, 2012 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on cefazolin sodium and telmisartan (the active ingredients of Cefazolin and Telmisartan, respectively), and Cefazolin and Telmisartan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Prozac cause Seizure Like Phenomena? - a second ago
- Could Lanoxin cause Gastritis Erosive? - 10 seconds ago
- Could Altace cause Hypotension? - 18 seconds ago
- Could Crestor cause Helicobacter Test Positive? - 19 seconds ago
- Fentanyl Transdermal System vs. Celebrex, side effect and effectiveness comparison - 25 seconds ago
- Noroxin vs. Levofloxacin, side effect and effectiveness comparison - 39 seconds ago
- Drug interactions of Dexamethasone and Ebrantil - 51 seconds ago
- Drug interactions of Ultram and Nyquil - 59 seconds ago
- Could Fenofibrate cause Multiple Allergies? - a minute ago
- Drug interactions of Serevent and Ciprofloxacin Hydrochloride - a minute ago